March 2, 2026: Gastrointestinal Lawsuits Involving Trulicity, Other GLP-1s Increase in March Eli Lilly and one other drug company are facing 3,363 lawsuits in a consolidated MDL, in which plaintiffs accuse the companies of failing to warn patients about the gastrointestinal risks of taking Trulicity and other GLP-1s
Additionally, auto reactive effector T cells that penetrate the blood brain barrier are another significant factor in MS
Data are presented as the mean standard deviation
Any type of exercise is good, so you can do whatever you enjoy
These medications can provide meaningful benefits for weight management and metabolic health, but questions about long-term use, maintenance, and stopping treatment are common
Teeth sensitivity is common with Zepbound, making hot or cold foods uncomfortable